AstraZeneca in the news

Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up

Read on: CNBC News

AstraZeneca's (AZN LN) Potential Blockbuster Pill Halves High Cholesterol

Read on: Bloomberg

After China probe, is AstraZeneca's new US$2.5 billion plan a blueprint for foreign firms?

Read on: SCMP

AstraZeneca to invest $2.5bn in China after scandal

Read on: Financial Times

AstraZeneca pays up to $1bn for biotech firm 'that could transform cell therapy'

Read on: The Guardian

Drug Giant AstraZeneca Buys Belgian Biotech EsoBiotec in $1 Billion Cancer Bet

Read on: Bloomberg

AstraZeneca buys cell therapy biotech in up to $1bn deal

Read on: Financial Times

Signs of relief for AstraZeneca as China courts foreign investors

Read on: SCMP

AstraZeneca hit with US class action lawsuit over China regulatory probes

Read on: Financial Times

Inside AstraZeneca's abandoned UK vaccine plant deal as Labour and Tories face questions over PS450m collapse

Read on: Independent

The inside story of Britain's failure to clinch PS450mn AstraZeneca deal

Read on: Financial Times

Failed AstraZeneca deal is no way to sell Labour's pro-growth ambitions

Read on: Financial Times

AstraZeneca sales jump despite troubles in China

Read on: Financial Times

AstraZeneca ditches plan to build PS450mn UK vaccine plant

Read on: Financial Times

Blow for Reeves as AstraZeneca ditches PS450m investment

Read on: BBC

Government hits back in AstraZeneca funding row

Read on: BBC

Tory slams Labour's collapse of PS450m AstraZeneca deal as 'terrible failure'

Read on: Express

AstraZeneca investment deal 'didn't add up for UK taxpayer', says minister

Read on: Independent

AstraZeneca rejected close to PS80mn in state support for cancelled Speke factory

Read on: Financial Times